Education
About Us
Working with TipRanks
Follow Us
C-MER Eye Care Holdings Limited (HK:3309)
:3309
3309 Stock Chart & Stats
HK$1.70
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$1.70
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$1.33 - HK$2.16
Previous CloseN/A
Volume360.00K
Average Volume (3M)495.46K
Market Cap
HK$1.84B
Enterprise ValueHK$1.85B
Total Cash (Recent Filing)HK$435.71M
Total Debt (Recent Filing)HK$423.12M
Price to Earnings (P/E)―
Beta1.10
Next Earnings
Mar 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.2%
Share Statistics
EPS (TTM)0.04
Shares Outstanding1,232,342,900
10 Day Avg. Volume419,185
30 Day Avg. Volume495,465
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)1.41
Price to Sales (P/S)1.30
P/FCF Ratio19.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.62
Revenue Forecast (FY)HK$19.13B
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet And Low LeverageA high equity ratio and low debt-to-equity provide a durable solvency buffer, lowering financial risk and interest burden. This balance-sheet strength gives the company flexibility to fund operations, invest in clinics or technology, and withstand demand shocks without relying heavily on external financing.
Leading Provider With Diversified Clinical ServicesOperating multiple hospitals and offering cataract, refractive and other specialty procedures creates diversified, service-based revenue streams. This business model produces recurring procedural demand, benefits from referral networks and insurer relationships, and supports stable patient volumes over the medium term.
Underlying Gross Margin Provides Reinvestment CapacityA ~31% gross margin on clinical services reflects pricing power and relatively scalable cost of goods for procedures. While lower than prior year, this margin base still supports reinvestment in equipment, training and service quality; if SG&A is controlled, it can underpin a return to operating profitability.
Bears Say
Severe Cash Flow Generation WeaknessZero operating and free cash flow undermines the company's ability to fund capital expenditure, service working capital needs, and sustain investments without external capital. This liquidity weakness is a material structural risk that constrains strategic options and increases reliance on financing until cash generation recovers.
Negative Operating And Net ProfitabilityNegative EBIT and net margins indicate the core business is not covering operating costs after recent pressures. Persistent operating losses erode equity and limit capacity to invest in growth or return capital. Without structural revenue recovery or cost reductions, profitability risks persist over months.
Deteriorating Return On EquityA swing to negative ROE signals the company is destroying shareholder value versus the prior year. This reflects weaker earnings quality and reduces the firm's attractiveness to capital providers, constraining funding and strategic initiatives until profit generation normalizes.
C-MER Eye Care Holdings Limited News
3309 FAQ
What was C-MER Eye Care Holdings Limited’s price range in the past 12 months?
C-MER Eye Care Holdings Limited lowest stock price was HK$1.33 and its highest was HK$2.16 in the past 12 months.
What is C-MER Eye Care Holdings Limited’s market cap?
C-MER Eye Care Holdings Limited’s market cap is HK$1.84B.
When is C-MER Eye Care Holdings Limited’s upcoming earnings report date?
C-MER Eye Care Holdings Limited’s upcoming earnings report date is Mar 31, 2026 which is in 36 days.
How were C-MER Eye Care Holdings Limited’s earnings last quarter?
C-MER Eye Care Holdings Limited released its earnings results on Aug 26, 2025. The company reported HK$0.041 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.041.
Is C-MER Eye Care Holdings Limited overvalued?
According to Wall Street analysts C-MER Eye Care Holdings Limited’s price is currently Overvalued.
Does C-MER Eye Care Holdings Limited pay dividends?
C-MER Eye Care Holdings Limited pays a Annually dividend of HK$0.02 which represents an annual dividend yield of 1.2%. See more information on C-MER Eye Care Holdings Limited dividends here
What is C-MER Eye Care Holdings Limited’s EPS estimate?
C-MER Eye Care Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does C-MER Eye Care Holdings Limited have?
C-MER Eye Care Holdings Limited has 1,232,342,900 shares outstanding.
What happened to C-MER Eye Care Holdings Limited’s price movement after its last earnings report?
C-MER Eye Care Holdings Limited reported an EPS of HK$0.041 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.478%.
Which hedge fund is a major shareholder of C-MER Eye Care Holdings Limited?
Currently, no hedge funds are holding shares in HK:3309
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
C-MER Eye Care Holdings Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-12.66%
12-Months-Change
Fundamentals
Return on Equity
-6.41%
Trailing 12-Months
Asset Growth
-0.42%
Trailing 12-Months
Company Description
C-MER Eye Care Holdings Limited
C-MER Eye Care Holdings Ltd. engages in the provision of treatments and therapy services for ophthalmic diseases. It operates through the Provision of Ophthalmic Services and the Sale of Vision Aid Products segments. The company was founded by Shun Chiu Lam on February 1, 2016 and is headquartered in Hong Kong.
Technical Analysis
Options Prices
Currently, No data available
---